Literature DB >> 25056900

Inhibition of phosphorylated-STAT1 nuclear translocation and antiviral protein expression in human brain vascular adventitial fibroblasts infected with varicella-zoster virus.

Maria A Nagel1, Stephanie F James2, Igor Traktinskiy2, Ann Wyborny2, Alexander Choe2, April Rempel2, Nicholas L Baird2, Don Gilden3.   

Abstract

In varicella-zoster virus (VZV)-infected primary human brain vascular adventitial fibroblasts (BRAFs), levels of beta interferon (IFN-β,) STAT1, and STAT2 transcripts as well as STAT1 and STAT2 protein were decreased. IFN-α transcript levels were increased but not secreted IFN-α protein levels. Compared to IFN-α-treated control results, in VZV-infected BRAFs, phosphorylated STAT1 did not translocate to the nucleus, resulting in impaired downstream expression of interferon-inducible antiviral Mx1. Overall, VZV interference with the type I interferon pathway may promote virus persistence in cerebral arteries.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056900      PMCID: PMC4178816          DOI: 10.1128/JVI.01945-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3.

Authors:  Huifang Zhu; Chunfu Zheng; Junji Xing; Shuai Wang; Shuping Li; Rongtuan Lin; Karen L Mossman
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 2.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

3.  Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation.

Authors:  Karen E Johnson; David M Knipe
Journal:  Virology       Date:  2009-10-31       Impact factor: 3.616

4.  Varicella zoster virus DNA does not accumulate in infected human neurons.

Authors:  Nicholas L Baird; Jacqueline L Bowlin; Xiaoli Yu; Stipan Jonjić; Jürgen Haas; Randall J Cohrs; Don Gilden
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

5.  Varicella-zoster virus transcriptome in latently infected human ganglia.

Authors:  Maria A Nagel; Alexander Choe; Igor Traktinskiy; Robert Cordery-Cotter; Don Gilden; Randall J Cohrs
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

Review 6.  Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity.

Authors:  Otto Haller; Georg Kochs
Journal:  J Interferon Cytokine Res       Date:  2010-12-19       Impact factor: 2.607

7.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

8.  Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses.

Authors:  Nandini Sen; Marvin Sommer; Xibing Che; Kris White; William T Ruyechan; Ann M Arvin
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

9.  Varicella zoster virus infection of highly pure terminally differentiated human neurons.

Authors:  Xiaoli Yu; Scott Seitz; Tiffany Pointon; Jacqueline L Bowlin; Randall J Cohrs; Stipan Jonjić; Jürgen Haas; Mary Wellish; Don Gilden
Journal:  J Neurovirol       Date:  2012-12-12       Impact factor: 3.739

10.  Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha.

Authors:  Chia-Chi Ku; Leigh Zerboni; Hideki Ito; Brad S Graham; Mark Wallace; Ann M Arvin
Journal:  J Exp Med       Date:  2004-09-27       Impact factor: 14.307

View more
  7 in total

1.  Pseudorabies Virus dUTPase UL50 Induces Lysosomal Degradation of Type I Interferon Receptor 1 and Antagonizes the Alpha Interferon Response.

Authors:  Rui Zhang; Aotian Xu; Chao Qin; Qiong Zhang; Shifan Chen; Yue Lang; Mengdong Wang; Chuang Li; Wenhai Feng; Rui Zhang; Zhengfan Jiang; Jun Tang
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

2.  Insights into the pathogenesis of varicella viruses.

Authors:  Océane Sorel; Ilhem Messaoudi
Journal:  Curr Clin Microbiol Rep       Date:  2019-07-06

3.  Simian varicella virus inhibits the interferon gamma signalling pathway.

Authors:  Werner J D Ouwendijk; Suzanne van Veen; Ravi Mahalingam; Georges M G M Verjans
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

4.  Differential regulation of matrix metalloproteinases in varicella zoster virus-infected human brain vascular adventitial fibroblasts.

Authors:  Maria A Nagel; Alexander Choe; April Rempel; Ann Wyborny; Kurt Stenmark; Don Gilden
Journal:  J Neurol Sci       Date:  2015-09-16       Impact factor: 3.181

5.  Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms.

Authors:  Marieke C Verweij; Mary Wellish; Travis Whitmer; Daniel Malouli; Martin Lapel; Stipan Jonjić; Juergen G Haas; Victor R DeFilippis; Ravi Mahalingam; Klaus Früh
Journal:  PLoS Pathog       Date:  2015-05-14       Impact factor: 6.823

6.  Double-stranded RNA induces chicken T-cell lymphoma apoptosis by TRIF and NF-κB.

Authors:  Haitao Zou; Ruixue Su; Jing Ruan; Hongxia Shao; Kun Qian; Jianqiang Ye; Yongxiu Yao; Venugopal Nair; Aijian Qin
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

7.  Targeted RNA Sequencing of VZV-Infected Brain Vascular Adventitial Fibroblasts Indicates That Amyloid May Be Involved in VZV Vasculopathy.

Authors:  Andrew N Bubak; Christina N Como; James E Hassell; Teresa Mescher; Seth E Frietze; Christy S Niemeyer; Randall J Cohrs; Maria A Nagel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.